The interaction between methylene blue and the cholinergic system
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The inhibitory effects of methylene blue (MB) on different types of cholinesterases and [3 H]‐N‐methylscopolamine ([3 H]‐NMS) binding to muscarinic receptors were studied. Human plasma from young healthy male volunteers, purified human pseudocholinesterase and purified bovine true acetylcholinesterase were incubated with acetylcholine and increasing concentrations of MB (0.1–100 μmol l−1) in the presence of the pH‐indicator m‐nitrophenol for 30 min at 25°C. The amount of acetic acid produced by the enzymatic hydrolysis of acetylcholine was determined photometrically. Rat cardiac left ventricle homogenate was incubated with [3 H]‐NMS and with increasing concentrations of MB (0.1 nmol l−1–100 μmol l−1) at 37°C for 20 min. The binding of [3 H]‐NMS to the homogenate was quantified by a standard liquid scintillation technique. MB inhibited the esterase activity of human plasma, human pseudocholinesterase and bovine acetylcholinesterase concentration‐dependently with IC 50 values of 1.05±0.05 μmol l−1, 5.32±0.36 μmol l−1 and 0.42±0.09 μmol l−1, respectively. MB induced complete inhibition of the esterase activity of human plasma and human pseudocholinesterase, whereas bovine acetylcholinesterase was maximally inhibited by 73±3.3%. MB was able to inhibit specific [3 H]‐NMS binding to rat cardiac left ventricle homogenate completely with an IC 50 value of 0.77±0.03 μmol l−1, which resulted in a Ki value for MB of 0.58±0.02 μmol l−1. In conclusion, MB may be considered as a cholinesterase inhibitor with additional, relevant affinity for muscarinic binding sites at concentrations at which MB is used for investigations into the endothelial system. In our opinion these interactions between MB and the cholinergic system invalidate the use of MB as a tool for the investigation of the L‐arginine‐NO‐pathway, in particular when muscarinic receptor stimulation is involved. British Journal of Pharmacology (1997) 122, 95–98; doi:10.1038/sj.bjp.0701355
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidation of nitrogen-oxides by bound dioxygen in hemoproteins
Doyle, M. P., & Hoekstra, J. W. (1981) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(00)80291-3 · Cited by 643 · cited 1×
“Beside this oxyhaemoglobin-like e ect (Doyle & Hoekstra, 1981) MB interacts with the active haeme centre (Martin et al., 1985) and the haeme-de®cient apoenzyme (Tsai et al., 1983) of soluble guanylate cyclase, thereby inhibiting the formation of the relaxant second messenger guanosine-3',5'-cyclic…”
Method
Cited by
A review on Alzheimer's disease pathophysiology and its management: an update
Kumar, A., Singh, A., & Ekavali (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.09.004 · Cited by 1,578
Therapeutics of Alzheimer's disease: Past, present and future
Anand, R., Gill, K. D., & Mahdi, A. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.004 · Cited by 747
Adrenergic and Muscarinic Receptors in the Human Heart
Brodde, O.-E., & Michel, M. C. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01425-x · Cited by 673
Cellular and molecular actions of Methylene Blue in the nervous system
Oz, M., Lorke, D. E., Hasan, M., & Petroianu, G. A. (2011) · Medicinal Research Reviews · doi:10.1002/med.20177 · Cited by 443
“Lest we forget you — methylene blue …”
Schirmer, R. H., Adler, H., Pickhardt, M., & Mandelkow, E. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.12.012 · Cited by 414
Metadata
- Authors
- Pfaffendorf, M., Bruning, T. A., Batink, H. D., & Van Zwieten, P. A.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1997-09
- Volume
- 122
- Issue
- 1
- Pages
- 95-98
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2110657758
- Cited by
- 62
- References
- 1
- FWCI
- 2.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.